NIH-funded research R01 grant

Why the heart enlarges with mitral valve leakage (mitral regurgitation)

Official title: Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Mitral Regurgitation

Funded at Utah State Higher Education System--University of Utah · NIH-11321256 · Data updated 2026-11-12

This project looks at how leaking of the mitral valve causes heart muscle cells to stretch and the left ventricle to enlarge in adults with mitral regurgitation.

More Mitral Regurgitation research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startJune 1, 2023
Project endApril 30, 2027
Funding year2026
Award (this year)$582,272
NIH project number5R01HL166513-04
Project IDNIH-11321256 on NIH RePORTER

Who could benefit from this research

Could help

Adults (age 21 and older) with moderate to severe mitral regurgitation or related left ventricular enlargement would be the most relevant group for this work.

Less likely to help

People without mitral valve leakage, pediatric patients, or those whose heart failure is due to unrelated causes are unlikely to benefit directly from this project.

What this research studies

This work aims to explain the molecular steps that make the heart remodel and enlarge when the mitral valve leaks. The team will use laboratory and animal models and molecular analyses to trace how cardiac muscle cells change shape and size, with a focus on the ATM protein's role. They will examine heart tissue, cell signaling, and structural changes to connect valve leakage to the eccentric hypertrophy that leads to heart failure. The findings are intended to point to molecular targets for future therapies or tests.

Why it matters

Potential benefit: If successful, this research could identify molecular targets that help prevent or slow heart weakening in people with mitral regurgitation.

How similar studies have gone: Prior large-animal and some rat models have explored mitral regurgitation, but robust mouse models and targeted molecular work on ATM in this setting are limited and relatively novel.

Where this research is happening

  • Utah State Higher Education System--University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Drakos, Stavros George — Utah State Higher Education System--University of Utah
  • Study coordinator: Drakos, Stavros George

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.